2024 Q1 Form 10-K Financial Statement

#000109181824000032 Filed on March 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $173.5K $102.0K
YoY Change 20.95% -19.43%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $173.5K $102.0K $427.0K
YoY Change 20.95% -19.43% -19.13%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $137.7K -$102.1K $4.847M
YoY Change -4.0% -19.36% -1017.92%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $137.7K -$102.1K -$4.847M
YoY Change -196.0% -19.35% 817.92%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.10
Diluted Earnings Per Share $0.00 $0.00 -$0.10
COMMON SHARES
Basic Shares Outstanding 47.64M shares 56.14M shares 49.08M shares
Diluted Shares Outstanding 47.64M shares 49.08M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $480.00 $1.180K $1.180K
YoY Change 1100.0% 1585.71% 1585.71%
Cash & Equivalents $482.00 $1.180K $1.180K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $482.00 $1.180K $1.180K
YoY Change 1020.93% 1516.44% 1585.71%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $482.00 $1.180K $1.180K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $482.00 $1.180K $1.180K
YoY Change 1020.93% 1516.44% 1585.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $58.54K $12.45K $12.45K
YoY Change 2548.87% 1560.0% 1560.0%
Accrued Expenses $251.0K $207.3K $207.3K
YoY Change -84.84% -86.52% -86.52%
Deferred Revenue $35.80K $35.80K
YoY Change
Short-Term Debt $237.3K $154.3K $154.3K
YoY Change 9.45% -20.3% -20.3%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $546.8K $409.9K $409.9K
YoY Change -71.39% -76.81% -76.81%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $546.8K $409.9K $409.9K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $546.8K $409.9K $409.9K
YoY Change -71.39% -76.81% -76.81%
SHAREHOLDERS EQUITY
Retained Earnings -$95.93M -$95.79M
YoY Change 5.32% 5.33%
Common Stock $4.763K $4.763K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$546.3K -$408.7K -$408.7K
YoY Change
Total Liabilities & Shareholders Equity $482.00 $1.180K $1.180K
YoY Change 1020.93% 1516.44% 1585.71%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $137.7K -$102.1K -$4.847M
YoY Change -196.0% -19.35% 817.92%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$83.69K -$45.34K -$165.3K
YoY Change 259.92% 506.96% 211.76%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $82.99K 36.45K 166.5K
YoY Change 257.38% 389.26% 213.97%
NET CHANGE
Cash From Operating Activities -$83.69K -45.34K -165.3K
Cash From Investing Activities
Cash From Financing Activities $82.99K 36.45K 166.5K
Net Change In Cash -$698.00 -8.890K 1.110K
YoY Change 2226.67% 44350.0% -5650.0%
FREE CASH FLOW
Cash From Operating Activities -$83.69K -$45.34K -$165.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 brvo Notes Receivable Related Party
NotesReceivableRelatedParty
usd
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001444839
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
usd
CY2022Q4 brvo Notes Receivable Related Party
NotesReceivableRelatedParty
usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 brvo Rescission With Rpi
RescissionWithRpi
usd
CY2022 brvo Discontinued Operations
DiscontinuedOperations
usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023 us-gaap Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 brvo Accrued Board Of Directors Fees Contributed To Capital
AccruedBoardOfDirectorsFeesContributedToCapital
usd
CY2022 brvo Due To Related Parties Contributed To Capital
DueToRelatedPartiesContributedToCapital
usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
usd
CY2023Q4 brvo Net Notes Receivable Related Parties
NetNotesReceivableRelatedParties
usd
CY2022Q4 brvo Net Notes Receivable Related Parties
NetNotesReceivableRelatedParties
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity File Number
EntityFileNumber
000-53505
CY2023 dei Entity Registrant Name
EntityRegistrantName
BRAVO MULTINATIONAL INCORPORATED
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-4068651
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
2020 General Booth Blvd
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 230
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Virginia Beach
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
12802415 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47641011 shares
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1180 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2023Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2725 usd
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2725 usd
CY2023Q4 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
-418000 usd
CY2022Q4 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
-418000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1180 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
73 usd
CY2023Q4 us-gaap Assets
Assets
1180 usd
CY2022Q4 us-gaap Assets
Assets
73 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
12453 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
750 usd
CY2023Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
35800 usd
CY2022Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
35800 usd
CY2023Q4 brvo Due To Related Parties
DueToRelatedParties
154280 usd
CY2022Q4 brvo Due To Related Parties
DueToRelatedParties
193570 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
207250 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1537417 usd
CY2023Q4 us-gaap Liabilities
Liabilities
409783 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1767537 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47641010 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47641010 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47641010 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47641010 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4763 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4763 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
95374299 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89168493 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95787765 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90940720 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-408703 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1767464 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1180 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18071 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8793 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
158974 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
44265 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
250000 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
475000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
427045 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
528058 usd
CY2023 brvo Loss From Operations Before Goodwill Impairment
LossFromOperationsBeforeGoodwillImpairment
-427045 usd
CY2022 brvo Loss From Operations Before Goodwill Impairment
LossFromOperationsBeforeGoodwillImpairment
-528058 usd
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
4420100 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4847145 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
528058 usd
CY2023 us-gaap Profit Loss
ProfitLoss
4847145 usd
CY2022 us-gaap Profit Loss
ProfitLoss
528058 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49084847 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49084847 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47641010 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47641010 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1239506 usd
CY2022 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
100 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-528058 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1767464 usd
CY2023 brvo Merger With Rpi And Share Issuance
MergerWithRpiAndShareIssuance
4420000 usd
CY2023 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
1785906 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4847145 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-408703 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4847145 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-528058 usd
CY2023 brvo Discontinued Operations
DiscontinuedOperations
4420100 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-40 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11703 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-16 usd
CY2023 brvo Increase Decrease In Accrued Board Of Directors Fees
IncreaseDecreaseInAccruedBoardOfDirectorsFees
250000 usd
CY2022 brvo Increase Decrease In Accrued Board Of Directors Fees
IncreaseDecreaseInAccruedBoardOfDirectorsFees
475000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-165342 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53034 usd
CY2022 us-gaap Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
100 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
166449 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
52914 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
166449 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53014 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1107 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-20 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1180 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73 usd
CY2023 brvo Accrued Board Of Directors Fees Contributed To Capital
AccruedBoardOfDirectorsFeesContributedToCapital
1580167 usd
CY2023 brvo Due To Related Parties Contributed To Capital
DueToRelatedPartiesContributedToCapital
205739 usd
CY2023 brvo Net Royalty Percentage
NetRoyaltyPercentage
0.15 pure
CY2023Q4 us-gaap Area Of Land
AreaOfLand
76.63
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zD1m1Gbbw1e1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86C_zoO0uNROYVEk">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
42312 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
42312 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2017Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
42312 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2023 brvo Rent Expense
RentExpense
0 usd
CY2022 brvo Rent Expense
RentExpense
0 usd
CY2023 us-gaap Proceeds Accounts Receivable Previously Written Off Recovery
ProceedsAccountsReceivablePreviouslyWrittenOffRecovery
42312 usd
CY2023Q4 brvo Notes Receivable Related Parties Current Gross
NotesReceivableRelatedPartiesCurrentGross
418000 usd
CY2022Q4 brvo Notes Receivable Related Parties Current Gross
NotesReceivableRelatedPartiesCurrentGross
418000 usd
CY2023Q4 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
-418000 usd
CY2022Q4 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
-418000 usd
CY2023Q4 brvo Due To Related Parties
DueToRelatedParties
154280 usd
CY2022Q4 brvo Due To Related Parties
DueToRelatedParties
193570 usd
CY2023 brvo Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
1720 usd
CY2022 brvo Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
0 usd
CY2023 brvo Filing Fees
FilingFees
2795 usd
CY2022 brvo Filing Fees
FilingFees
0 usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 brvo Shares Authorized
SharesAuthorized
1050000000 shares
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4420000 usd
CY2023Q4 us-gaap Shares Issued
SharesIssued
4516667 shares
CY2023Q3 us-gaap Shares Issued
SharesIssued
8500000 shares
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4420000 usd
CY2023Q4 brvo Share Exchange Agreement Description
ShareExchangeAgreementDescription
share exchange agreement was rescinded by all parties and the issued shares were returned.

Files In Submission

Name View Source Status
0001091818-24-000032-index-headers.html Edgar Link pending
0001091818-24-000032-index.html Edgar Link pending
0001091818-24-000032.txt Edgar Link pending
0001091818-24-000032-xbrl.zip Edgar Link pending
brvo-20231231.xsd Edgar Link pending
brvo1231202310k.htm Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
brvo-20231231_cal.xml Edgar Link unprocessable
brvo-20231231_def.xml Edgar Link unprocessable
brvo-20231231_lab.xml Edgar Link unprocessable
brvo1231202310k_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
brvo-20231231_pre.xml Edgar Link unprocessable